Dr Reddy's Laboratories Ltd
Healthcare
French firm Sanofi looks to sell select non-core drugs to local pharma company
Sanofi India Ltd, local unit of the French drugmaker, is in advanced discussions to sell a non-core portfolio of over-the-counter drugs ......
General
India, Russia sign more deals to make 300 mn Sputnik V vaccines
India will produce about 300 million doses of Russia's Sputnik V coronavirus vaccines next year, a Russian official was quoted ......
Healthcare
Dr Reddy's to buy Glenmark's select anti-allergy brands in Russia, other countries
Dr. Reddy’s Laboratories Ltd has agreed to acquire select anti-allergy brands from Glenmark Pharmaceuticals Ltd in Russia, Ukraine, Kazakhstan and ......
Healthcare
Russian wealth fund to sell 100 mn doses of COVID-19 vaccine to Dr Reddy's
Russia's sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian drug company ......
Healthcare
Dr Reddy's tweaks deal with Wockhardt on Covid-19 impact
Dr. Reddy's Laboratories Ltd said on Wednesday it has bought a plant as well as select divisions of Wockhardt Ltd’s ......
Markets
Sensex, Nifty rise on signs of slowing virus spread in hot spots; pharma shares jump
Indian shares recorded their biggest single-day gain in over a decade on Tuesday on signs of progress against the coronavirus ......
Markets
Nifty, Sensex decline as coronavirus cases jump to 28
Indian shares closed lower on Wednesday after the country's health minister confirmed the number of coronavirus cases had risen sharply ......
Healthcare
Dr Reddy's Labs to acquire part of Wockhardt's generics business for $260 mn
Dr Reddy's Laboratories Ltd has agreed to acquire select divisions of Wockhardt Ltd’s generics drug business in India and a ......
Healthcare
Former Springforth Capital exec gets angel funding for OTC venture
Hilt Brands India Pvt. Ltd, which offers over-the-counter (OTC) healthcare products, has raised angel funding from a few wealthy individuals, ......
Healthcare
Why govt's plan to cap prices of more drugs may have a silver lining for investors
Indian pharmaceuticals companies, which are striving hard to maintain its growth and facing greater regulatory pressure in their key market ......